1. A stealth antigen SPESP1, which is epigenetically silenced in tumors, is a suitable target for cancer immunotherapy. Issue 7 (3rd June 2021) Authors: Kosaka, Akemi; Yajima, Yuki; Hatayama, Mayumi; Ikuta, Katsuya; Sasaki, Takaaki; Hirai, Noriko; Yasuda, Syunsuke; Nagata, Marino; Hayashi, Ryusuke; Harabuchi, Shohei; Ohara, Kenzo; Ohara, Mizuho; Kumai, Takumi; Ishibashi, Kei; Hirata‐Nozaki, Yui; Nagato, Toshihiro; Oikawa, Kensuke; Harabuchi, Yasu... Journal: Cancer science Issue: Volume 112:Issue 7(2021) Page Start: 2705 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A tumor metastasis‐associated molecule TWIST1 is a favorable target for cancer immunotherapy due to its immunogenicity. Issue 8 (27th May 2022) Authors: Yajima, Yuki; Kosaka, Akemi; Ishibashi, Kei; Yasuda, Shunsuke; Komatsuda, Hiroki; Nagato, Toshihiro; Oikawa, Kensuke; Kitada, Masahiro; Takekawa, Masanori; Kumai, Takumi; Ohara, Kenzo; Ohkuri, Takayuki; Kobayashi, Hiroya Journal: Cancer science Issue: Volume 113:Issue 8(2022) Page Start: 2526 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Celecoxib promotes the efficacy of STING‐targeted therapy by increasing antitumor CD8+ T‐cell functions via modulating glucose metabolism of CD11b+Ly6G+ cells. Issue 8 (22nd December 2022) Authors: Kosaka, Akemi; Yajima, Yuki; Yasuda, Shunsuke; Komatsuda, Hiroki; Nagato, Toshihiro; Oikawa, Kensuke; Kobayashi, Hiroya; Ohkuri, Takayuki Journal: International journal of cancer Issue: Volume 152:Issue 8(2023) Page Start: 1685 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Effects of STING stimulation on macrophages: STING agonists polarize into "classically" or "alternatively" activated macrophages?. Issue 2 (1st February 2018) Authors: Ohkuri, Takayuki; Kosaka, Akemi; Nagato, Toshihiro; Kobayashi, Hiroya Journal: Human vaccines & immunotherapeutics Issue: Volume 14:Issue 2(2018) Page Start: 285 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Epigenetic modification augments the immunogenicity of human leukocyte antigen G serving as a tumor antigen for T cell-based immunotherapy. (2nd June 2016) Authors: Ishibashi, Kei; Kumai, Takumi; Ohkuri, Takayuki; Kosaka, Akemi; Nagato, Toshihiro; Hirata, Yui; Ohara, Kenzo; Oikawa, Kensuke; Aoki, Naoko; Akiyama, Naoko; Sado, Masatoshi; Kitada, Masahiro; Harabuchi, Yasuaki; Celis, Esteban; Kobayashi, Hiroya Journal: Oncoimmunology Issue: Volume 5:Number 6(2016) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Expression of miR-17-92 enhances anti-tumor activity of T-cells transduced with the anti-EGFRvIII chimeric antigen receptor in mice bearing human GBM xenografts. Issue 1 (16th December 2013) Authors: Ohno, Masasuke; Ohkuri, Takayuki; Kosaka, Akemi; Tanahashi, Kuniaki; June, Carl H; Natsume, Atsushi; Okada, Hideho Journal: Journal for immunotherapy of cancer Issue: Volume 1:Issue 1(2013) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Expression of placenta-specific 1 and its potential for eliciting anti-tumor helper T-cell responses in head and neck squamous cell carcinoma. (1st January 2021) Authors: Hayashi, Ryusuke; Nagato, Toshihiro; Kumai, Takumi; Ohara, Kenzo; Ohara, Mizuho; Ohkuri, Takayuki; Hirata-Nozaki, Yui; Harabuchi, Shohei; Kosaka, Akemi; Nagata, Marino; Yajima, Yuki; Yasuda, Syunsuke; Oikawa, Kensuke; Kono, Michihisa; Kishibe, Kan; Takahara, Miki; Katada, Akihiro; Hayashi, Tatsuy... Journal: Oncoimmunology Issue: Volume 10:Number 1(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. IFN-γ- and IL-17-producing CD8+ T (Tc17-1) cells in combination with poly-ICLC and peptide vaccine exhibit antiglioma activity. Issue 6 (30th June 2021) Authors: Ohkuri, Takayuki; Kosaka, Akemi; Ikeura, Maki; Salazar, Andres M; Okada, Hideho Journal: Journal for immunotherapy of cancer Issue: Volume 9:Issue 6(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Immunomodulation via FGFR inhibition augments FGFR1 targeting T-cell based antitumor immunotherapy for head and neck squamous cell carcinoma. (31st December 2022) Authors: Kono, Michihisa; Komatsuda, Hiroki; Yamaki, Hidekiyo; Kumai, Takumi; Hayashi, Ryusuke; Wakisaka, Risa; Nagato, Toshihiro; Ohkuri, Takayuki; Kosaka, Akemi; Ohara, Kenzo; Kishibe, Kan; Takahara, Miki; Katada, Akihiro; Hayashi, Tatsuya; Kobayashi, Hiroya; Harabuchi, Yasuaki Journal: Oncoimmunology Issue: Volume 11:Number 1(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Mitogen‐activated protein kinase inhibition augments the T cell response against HOXB7‐expressing tumor through human leukocyte antigen upregulation. Issue 2 (28th November 2022) Authors: Komatsuda, Hiroki; Wakisaka, Risa; Kono, Michihisa; Kumai, Takumi; Hayashi, Ryusuke; Yamaki, Hidekiyo; Sato, Ryosuke; Nagato, Toshihiro; Ohkuri, Takayuki; Kosaka, Akemi; Ohara, Kenzo; Takahara, Miki; Katada, Akihiro; Kobayashi, Hiroya Journal: Cancer science Issue: Volume 114:Issue 2(2023) Page Start: 399 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗